[Changes of blood pressure, pulse and electrolytes following long-term treatment of Parkinsonism using Ro 8-0576 (L-Dopa and decarboxylase inhibitor)].

No abstract is available for this paper.

• Publication year

  1975

• Venue

  Der Nervenarzt

• Publication date

  1975-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 805381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Levodopa: A Review of its Pharmacological Properties and Therapeutic Uses with Particular Reference to Parkinsonism

  2012cited by this paper
• [Effect of dopamine on hemodynamics and renal function in patients with severe congestive heart failure].

  1973cited by this paper
• Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase

  1973cited by this paper
• [Longtime study on the effects of L-dopa therapy in parkinsonism].

  1973cited by this paper
• [Comparison of the effect of L-Dopa and of an L-Dopa+decarboxylase inhibitor combination in Parkinson's disease].

  1973cited by this paper
• [Comparative studies on the effects of dopamine and orciprenaline in healthy subjects: muscle blood flow, kidney blood flow, kidney function].

  1972cited by this paper
• Effects of Levodopa on Systolic Preejection Period, Blood Pressure, and Heart Rate during Acute and Chronic Treatment of Parkinson's Disease

  1972cited by this paper
• Recent advances in the treatment of Parkinsonism with drugs.

  1972cited by this paper
• [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].

  1972cited by this paper
• [Therapy of Parkinsonism using L-dopa in combination with a decarboxylase inhibitor].

  1972cited by this paper
• [L-dopa treatment of idiopathic orthostatic hypotension (postural hypotension)].

  1972cited by this paper
• [Therapy of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor (Ro 4-4602). Course in 71 patients].

  1972cited by this paper
• Adverse reactions during treatment of Parkinson's disease with levodopa.

  1971cited by this paper
• Levodopa in Parkinsonian patients with heart-disease.

  1971cited by this paper
• Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylation

  1971cited by this paper
• Failure of vitamin B6 to reverse the l-dopa effect in patients on a dopa decarboxylase inhibitor

  1971cited by this paper
• Plasma DOPA response to levodopa administration in man: Effects of a peripheral decarboxylase inhibitor

  1971cited by this paper
• L-Dopa in Parkinsonism and the Influence of Previous Thalamotomy

  1971cited by this paper
• Treatment of Parkinson's disease with levodopa and Ro 4‐4602

  1971cited by this paper
• Incidence of Side Effects from Levodopa during the Introduction of Treatment

  1971cited by this paper
• Cardiovascular effects of levodopa

  1971cited by this paper
• Status of the clinical evaluation of levodopa in the treatment of Parkinson's disease and syndrome

  1971cited by this paper
• Effects ofl-dopa alone and in combination with dopa decarboxylase inhibitors on the arterial pressure and heart rate of dogs

  1971cited by this paper
• Dopamine and disease.

  1970cited by this paper
• [Studies on the normal distribution of the human blood pressure. Direct blood pressure determination in 400 persons without heart failure or circulation disorders between the ages of 10 and 80 years].

  1970cited by this paper
• L-Dopa treatment in Parkinson's Disease.

  1970cited by this paper
• Pathological findings in idiopathic orthostatic hypotension. Its relationship with Parkinson's disease.

  1970cited by this paper
• Pupillary effects of levodopa therapy. Development of anisocoria in latent Horner's syndrome.

  1970cited by this paper
• Hypotension Caused by L-Dopa

  1970cited by this paper
• Renin-Aldosterone System in Parkinson's Disease

  1969cited by this paper
• Effects of L-dopa in Parkinson's disease.

  1969cited by this paper
• A Hemodynamic Comparison of Dopamine and Isoproterenol in Patients in Shock

  1969cited by this paper
• Action of dopamine on the human iris

  1969cited by this paper
• [Treatment of Parkinson's disease with L-dopa combined with a decarboxylase inhibitor].

  1969cited by this paper
• Attenuation of dopamine renal and mesenteric vasodilation by haloperidol: evidence for a specific dopamine receptor.

  1969cited by this paper
• Anesthetic-dopamine cardiac arrhythmias and their prevention by beta adrenergic blockade.

  1967cited by this paper
• Parkinsonism occurring during methyldopa therapy.

  1966cited by this paper
• EFFECT OF DOPAMINE IN MAN: AUGMENTATION OF SODIUM EXCRETION, GLOMERULAR FILTRATION RATE, AND RENAL PLASMA FLOW.

  1964cited by this paper
• NOREPINEPHRINE SYNTHESIS AND RELEASE IN VIVO MEDIATED BY 3,4-DIHYDROXYPHENETHYLAMINE.

  1963cited by this paper
• [Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

  1961cited by this paper

• [Risks of modern therapy for parkinsonism, and their consequences (author's transl)].

  1979cites this paper
• [Iatrogenic damage possibilities in the drug therapy of neurologic and psychiatric diseases].

  1977cites this paper
• Clinical Pharmacokinetics of Levodopa in Parkinson’s Disease

  1976cites this paper